Powering up the future of Cell & Gene Therapy

Where speed meets success, get more information here https://www.miltenyibiotec.com/lp/ful... Flexible, automated, and scalable—our solutions drive your cell and gene therapy to market faster. With GMP-compliant technologies, integrated platforms, and expert support at every step, we’re your partner in success. Watch the teaser to see seamless CGT in action.

Supporting your cell and gene therapy (CGT) journey: From development to commercialization with holistic manufacturing & analytical solutions plus comprehensive services.

Miltenyi Biotec is a global leader innovating technologies and services for patient-specific cell and gene therapies, turning scientific discoveries into practical treatments for personalized medicine. Having pioneered a groundbreaking method of cell separation, Miltenyi Biotec continues to sets industry standards today. With over 35 years of expertise, it supports customers in biomedical discoveries, translating them into clinical applications to enable access to new therapies for patients. Miltenyi Biotec focuses on providing integrated, advanced solutions to address complex challenges in the treatment of cancers, autoimmune diseases, and inherited disorders. Through its Miltenyi Bioindustry division, it provides expert guidance to therapy developers, helping them efficiently and cost-effectively navigate the path from process development to commercialization. Miltenyi Biotec is headquartered in Bergisch Gladbach and has a global team of 4,700 employees across 24 countries.